Aim: Previous studies suggested a positive association between eczema and cardiovascular disease (CVD), probably through enhanced systemic inflammation. However, several studies reported null findings about eczema and CVD, so the evidence is still controversial.
according to the International Classification of Diseases. Death registration is required by the Family Registration Law in Japan. Deaths from major CVD were defined by the International Classification of Diseases (ICD)-10 codes as follows: total CVD as I00 to I99; CHD as I20 to I25.9; heart failure as I50 to I50.9; cardiac arrhythmia as I40 to I40.9; total stroke as I60 to I60.9; ischemic stroke as I63 to I63.9 or I69.3; hemorrhagic stroke as I60 to I62.9 or I69 to I69.2; and aortic aneurysm or dissection as I71 to I71.9.
Results

Baseline Characteristics According to Self-Reported Frequency of Eczema
As shown in Table 1 , compared to individuals who "seldom" or "sometimes" had eczema, those who "often" had it tended to have higher level of body mass
Methods
Study Population
The Japan Collaborative Cohort (JACC) Study for Evaluation of Cancer Risks, sponsored by the Ministry of Education, Sport, and Science, conducted a baseline survey from 1988 to 1990 in 45 areas throughout Japan. Details of this survey have been described elsewhere 18) . Briefly, participants completed self-administered questionnaires about their lifestyles and medical histories, including previous CVD, cancer, and other diseases at baseline. The ethics committees of the Nagoya University School of Medicine and the Osaka University Graduate School of Medicine approved the study.
Of a total of 110,585 individuals, aged 40 to 79 years, 90,035 participants answered the question about their skin status. We further excluded participants who had any previous history of CHD, stroke or cancer at baseline. Consequently, 85,099 participants (35,489 men and 49,610 women) were included in this study.
Main Exposure: Self-Reported Frequency of Eczema
We asked participants about the frequency eczema appearance. Participants were requested to choose their answer to this question from the following three categories: "Often," "Sometimes," or "Seldom."
Other Cardiovascular Risk Factors
We selected a number of CVD risk factors, including age, sex, body mass index (sex-specific quintiles), history of hypertension, history of diabetes, smoking status (never, ex-smoker, or current smokers of 1 to 19 or ≥ 20 cigarettes per day), alcohol intake categories (never, ex-drinker, or current drinkers of ethanol at 1 to 22, 23 to 45, 46 to 68, or ≥ 69g per day), hours of walking (never, 1 to 2, 3 to 4, or ≥ 5 hours per week), sport participation (never, 1 to 2, 3 to 4, or ≥ 5 hours per week), perceived mental stress (low, medium, or high), hours of sleep (≤ 5, 6, 7, 8 or ≥ 9 hours per day), and educational attainment (attended school up to 12 years old, 15 years old, 18 years old, or older than 18 years old).
Outcomes: Mortality from Major Cardiovascular Diseases
Mortality surveillance was conducted systematically by checking death certificates, all of which were forwarded to their respective public health centers. Mortality data were then centralized at the Ministry of Health and Welfare, and the underlying causes of death were coded for the National Vital Statistics
Sensitivity Analysis
We reran models for CHD after stratifying participants by sex or age (40 to 59 vs. 60 to 79 years old), and obtained similar results to main results (p values for interactions by sex or age were 0.99 in three categories and 0.97 in two categories, or 0.34 in three categories and 0.24 in two categories, respectively) ( Table 3 ).
Discussion
In this prospective cohort study of Japanese men and women, we investigated the associations of eczema frequency with mortality from several major CVDs, and found that individuals who often had eczema had an increased risk of mortality from CHD, but not from stroke, heart failure, cardiac arrhythmia, stroke, either aortic aneurysm or dissection, compared to those who seldom or sometimes did. The association did not differ between men and women or younger and older people. To the best of our knowledge, this is the first study to find an association between eczema and mortality from CHD in a Japanese general population.
Previous reports about the association of eczemarelated diseases with CVD are mainly from Western countries. A previous meta-analysis by Miller et al. reported that psoriasis was associated with increased risk of CHD (odds ratio [OR] 1.5; 95% CI 1.2-1.9), but not stroke (OR 1.1; 95% CI 0.9-1.3), and in a subgroup analysis, such a significant association was seen only in hospital-based studies (OR 1.7; 95% CI index, histories of hypertension and diabetes, and high perceived mental stress, to be current drinkers, and to walk for more than five hours per week.
Association of Self-Reported Frequency of Eczema with Mortality from Several Major Cardiovascular Diseases
There were 5,628 CVD deaths during the 6,389,818 person-years of follow-up. As shown in Table 2 , 1,174 deaths resulted from CHD, 979 from heart failure, 366 from cardiac arrhythmia, 2,454 from total stroke, 1,357 from ischemic stroke, 1,013 from hemorrhagic stroke, and 201 from aortic aneurysm or dissection ( Table 2) . The age-, sex-adjusted model showed that, compared to individuals "seldom" having eczema, those "sometimes" or "often" having it had decreased or increased risk of mortality from CHD, respectively. Those "often" having eczema had an increased risk of mortality from CHD, than individuals who "seldom or sometimes" had it. Further adjustment for other CVD risk factors did not substantially change those associations; individuals who "sometimes" or "often" had eczema had 0.82 (95%CI: 0.69-0.97) or 1.26 (95%CI: 1.01-1.56) times the risk of mortality from CHD, compared to those who "seldom" did, respectively. Individuals who "often" had 1.30 (95%CI: 1.05-1.61) times the risk of mortality from CHD, compared with those who "seldom or sometimes" did it. There was no association of eczema with mortality from other CVD. 21) . In our study, frequent eczema was associated with increased risk of mortality from CHD but not from the other CVD. Inflammation may be associated with increased risk of stroke, another major atherosclerotic disease, as well as CHD, but its contribution to stroke risk was smaller than CHD risk [22] [23] [24] . In addition, the number of deaths from heart failure, cardiac arrhythmia and aortic aneurysm or dissection were fewer than those from CHD. Thus, we might have 17) . There are also some reports from Asian countries. Psoriasis Vulgaris was associated with CHD in a Japanese retrospective hospital-based study (OR: 1.27; 95%CI 1.01-1.58) 19) . A Chinese casecontrol study showed that the prevalence of myocardial infarction was 1.72 (95%CI 1.29-2.30) and 2.01 used several major CVDs as outcomes, and found that the high frequency of eczema was associated with risk of CHD, but not other CVD outcomes.
We should acknowledge several limitations. Firstly, eczema was self-reported and was defined without any precise medical examination by dermatologists. In addition, our questionnaire about eczema frequency has not been validated. Thus, we cannot rule out the possibility of misclassification for exposure. Secondly, we did not include information on using the adrenal cortex hormone as a potential confounding factor. The adrenal cortex hormone is often used as an eczema treatment, and the adrenal cortex hormone is also known as a risk factor for cardiovascular disease 34) . Thirdly, we used mortality data, but not incident data, for endpoints. Although the death certificates diagnoses' validity was confirmed 35, 36) , outcome misclassification is still possible. Fourthly, we assessed the association between eczema and CVD risk without considering blood lipids because data on blood concentrations of lipids was available for the subsample, but not for all participants. However, a previous study of US adults reported weak associations of eczema with history of high total cholesterol, told by a doctor or other health professionals 37) . When we analyzed the subsample of the participants who had serum total cholesterol level data (n 26,222), we found no HR alterations. The HRs (95%CIs) were 1.52 (1.01-2.28) in age-and sex-adjusted model and been able to identify only the association with risk of mortality from CHD.
Some skin diseases causing eczema may be associated with systemic inflammation. For example, in psoriasis, Th-1, Th-17 and Th-22 induce inflammation through deregulating interferon production and tumor necrosis factor 25) . In atopic dermatitis, there is a perivascular infiltration of immune factors or cells such as immunoglobulin E, T lymphocytes, and mast cells. C-reactant protein, thymus and activation-regulated chemokine, and immunoglobulin E, known as inflammatory markers, are elevated in patients with atopic eczema 13, 26) . Those inflammatory processes might have accelerated atherosclerosis [27] [28] [29] [30] [31] [32] [33] , leading to increased risk of mortality from CHD.
In the present study, individuals who reported having eczema "sometimes" had a decreased risk of mortality from CHD, compared to those "seldom" having eczema. One reason for this finding may be chance, but another may be a misclassification between those two groups. Considering that possibility, we also compared participants who reported having eczema "seldom or sometimes" to those having eczema "often," and found that individuals who "often" had eczema had an increased risk of mortality from CHD compared to those who "seldom or sometimes" had it.
This study's strengths include its prospective design and a long follow-up duration. In addition, we Tamakoshi (present chairperson of the study group), 1.51 (1.01-2.26) in age-, sex-and total cholesteroladjusted model. The corresponding multivariable HRs (CIs) were 1.38 (0.92-2.08) and 1.38 (0.91-2.08). Thus, total cholesterol was unlikely to confound the association in the present study.
In conclusion, self-reported eczema was associated with increased risk of mortality from CHD, but not other major CVD such as stroke in a Japanese general population. 
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